Caron Modeas

480 total citations
12 papers, 399 citations indexed

About

Caron Modeas is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Caron Modeas has authored 12 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Caron Modeas's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Caron Modeas is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Caron Modeas collaborates with scholars based in United States and Canada. Caron Modeas's co-authors include James E. Herndon, Vishram B. Rege, Robert W. Carey, Gary M. Strauss, Douglas J. Mathisen, Noah C. Choi, Mark R. Green, Yota Suzuki, Joseph Aisner and Rose Ruth Ellison and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Caron Modeas

12 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caron Modeas United States 9 355 190 37 29 28 12 399
MJ Matthews United States 4 206 0.6× 191 1.0× 33 0.9× 37 1.3× 45 1.6× 6 323
Yoh Watanabe Japan 8 322 0.9× 101 0.5× 41 1.1× 63 2.2× 56 2.0× 8 399
M. Neubauer United States 10 182 0.5× 196 1.0× 18 0.5× 30 1.0× 31 1.1× 20 304
Martin Kimmich Germany 9 239 0.7× 140 0.7× 47 1.3× 39 1.3× 29 1.0× 22 295
Wyatt C. Fowler United States 9 226 0.6× 130 0.7× 26 0.7× 17 0.6× 84 3.0× 11 351
F. Klinke Germany 8 416 1.2× 265 1.4× 61 1.6× 105 3.6× 94 3.4× 21 530
José Manuel Rodríguez-Paniagua Spain 6 357 1.0× 170 0.9× 41 1.1× 72 2.5× 46 1.6× 13 412
Francesco Oniga Italy 9 287 0.8× 150 0.8× 45 1.2× 21 0.7× 80 2.9× 16 374
Piotr Rudziński Poland 11 248 0.7× 99 0.5× 68 1.8× 57 2.0× 51 1.8× 35 362
José Padilla Spain 7 387 1.1× 220 1.2× 39 1.1× 84 2.9× 85 3.0× 18 490

Countries citing papers authored by Caron Modeas

Since Specialization
Citations

This map shows the geographic impact of Caron Modeas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caron Modeas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caron Modeas more than expected).

Fields of papers citing papers by Caron Modeas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caron Modeas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caron Modeas. The network helps show where Caron Modeas may publish in the future.

Co-authorship network of co-authors of Caron Modeas

This figure shows the co-authorship network connecting the top 25 collaborators of Caron Modeas. A scholar is included among the top collaborators of Caron Modeas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caron Modeas. Caron Modeas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Luikart, Sharon D., David A. Van Echo, Caron Modeas, et al.. (1993). Phase I/II Trial of Etoposide and Carboplatin in Extensive Small-Cell Lung Cancer. American Journal of Clinical Oncology. 16(2). 127–131. 13 indexed citations
2.
Graziano, Stephen L., James E. Herndon, Frederick Richards, et al.. (1993). A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer a cancer and leukemia group B study. Cancer. 72(1). 62–68. 9 indexed citations
3.
Suzuki, Yota, et al.. (1993). Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.. Journal of Clinical Oncology. 11(8). 1559–1565. 113 indexed citations
4.
Kreisman, Harvey, A. Lisbona, Linda K. Olson, et al.. (1993). Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer. Cancer. 72(5). 1588–1596. 21 indexed citations
5.
6.
Strauss, Gary M., James E. Herndon, Douglas J. Mathisen, et al.. (1992). Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.. Journal of Clinical Oncology. 10(8). 1237–1244. 175 indexed citations
7.
8.
Doll, D C, Stephen L. Graziano, John Ellerton, et al.. (1991). Carboplatin and vinblastine in advanced non-small-cell lung cancer: a phase II study. Cancer Chemotherapy and Pharmacology. 29(1). 71–74. 4 indexed citations
9.
Kreisman, Harvey, et al.. (1990). Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a cancer and leukemia group B study. European Journal of Cancer and Clinical Oncology. 26(10). 1057–1060. 17 indexed citations
10.
Ringenberg, Q. Scott, Kathleen J. Propert, Hyman B. Muss, et al.. (1990). Clinical cardiotoxicity of esorubicin (4′-deoxydoxorubicin,DxDx): Prospective studies with serial gated heart scans and reports of selected cases. Investigational New Drugs. 8(2). 221–226. 2 indexed citations
11.
Ringenberg, Q. Scott, Michael C. Perry, Kathleen J. Propert, et al.. (1988). Phase II trial of 4′‐deoxydoxorubicin (DxDx) in non‐small cell lung cancer: A cancer and leukemia group B trial. Medical and Pediatric Oncology. 16(1). 27–29. 3 indexed citations
12.
Luikart, Sharon D., et al.. (1987). High-dose etoposide therapy for extensive small cell lung cancer: a Cancer and Leukemia Group B Study.. PubMed. 71(5). 533–4. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by MJ Matthews Breakdown of academic impact, for papers by Yoh Watanabe Breakdown of academic impact, for papers by M. Neubauer Breakdown of academic impact, for papers by Martin Kimmich Breakdown of academic impact, for papers by Wyatt C. Fowler Breakdown of academic impact, for papers by F. Klinke Breakdown of academic impact, for papers by José Manuel Rodríguez-Paniagua Breakdown of academic impact, for papers by Francesco Oniga Breakdown of academic impact, for papers by Piotr Rudziński Breakdown of academic impact, for papers by José Padilla
Rankless by CCL
2026